Charles River announces ‘continued momentum’ in digital pathology platform

Charles River (CRL) Laboratories International announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates study timelines, and enhances pathologist efficiency, and supports the reduction of animal use in nonclinical research where scientifically appropriate. By fully integrating digital pathology across the histology and pathology workflow, Charles River is committed to cutting at least one week from standard pathology timelines while maintaining Good Laboratory Practice rigor and regulatory readiness. These efficiency gains are driven by the combination of a fully integrated histology laboratory information management system, AI-powered slide quality control, and validated digital primary pathology reviews.